mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.004 |
mRNA |
AZD6244 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.004 |
mRNA |
Zibotentan |
GDSC1000 |
pan-cancer |
AAC |
-0.094 |
0.005 |
mRNA |
phenformin |
GDSC1000 |
pan-cancer |
AAC |
0.084 |
0.006 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.007 |
mRNA |
HG-5-113-01 |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.008 |
mRNA |
PIK-93 |
CTRPv2 |
pan-cancer |
AAC |
-0.097 |
0.008 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.097 |
0.008 |
mRNA |
Erlotinib |
gCSI |
pan-cancer |
AAC |
-0.16 |
0.008 |
mRNA |
Bexarotene |
GDSC1000 |
pan-cancer |
AAC |
0.094 |
0.008 |